Literature DB >> 25059647

Ruthenium-catalyzed cycloadditions of 1-haloalkynes with nitrile oxides and organic azides: synthesis of 4-haloisoxazoles and 5-halotriazoles.

James S Oakdale1, Rakesh K Sit, Valery V Fokin.   

Abstract

(Cyclopentadienyl)(cyclooctadiene) ruthenium(II) chloride [CpRuCl(cod)] catalyzes the reaction between nitrile oxides and electronically deficient 1-choro-, 1-bromo-, and 1-iodoalkynes leading to 4-haloisoxazoles. Organic azides are also suitable 1,3-dipoles, resulting in 5-halo-1,2,3-triazoles. These air-tolerant reactions can be performed at room temperature with 1.25 equivalents of the respective 1,3-dipole relative to the alkyne component. Reactive 1-haloalkynes include propiolic amides, esters, ketones, and phosphonates. Post-functionalization of the halogenated azole products can be accomplished by using palladium-catalyzed cross-coupling reactions and by manipulation of reactive amide groups. The lack of catalysis observed with [Cp*RuCl(cod)] (Cp* = pentamethylcyclopentadienyl) is attributed to steric demands of the Cp* (η(5)-C5Me5) ligand in comparison to the parent Cp (η(5)-C5H5). This hypothesis is supported by the poor reactivity of [(η(5)-C5Me4CF3)RuCl(cod)], which serves as a an isosteric mimic of Cp* and as an isoelectronic analogue of Cp.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alkynes; cycloadditions; halides; regioselectivity; ruthenium

Mesh:

Substances:

Year:  2014        PMID: 25059647      PMCID: PMC4442801          DOI: 10.1002/chem.201402559

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  55 in total

1.  Preparation, electrochemical oxidation, and XPS studies of unsymmetrical ruthenocenes bearing the pentamethylcyclopentadienyl ligand.

Authors:  P G Gassman; C H Winter
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

2.  Use of iodoacetylene as a dipolarphile in the synthesis of 5-iodoisoxazole derivatives.

Authors:  Y Y Ku; T Grieme; P Sharma; Y M Pu; P Raje; H Morton; S King
Journal:  Org Lett       Date:  2001-12-27       Impact factor: 6.005

3.  Triazole: a unique building block for the construction of functional materials.

Authors:  Michal Juríček; Paul H J Kouwer; Alan E Rowan
Journal:  Chem Commun (Camb)       Date:  2011-05-09       Impact factor: 6.222

4.  A versatile iron-catalyzed protocol for the one-pot synthesis of isoxazoles or isoxazolines from the same propargylic alcohols.

Authors:  Olivier Debleds; Eric Gayon; Emilie Ostaszuk; Emmanuel Vrancken; Jean-Marc Campagne
Journal:  Chemistry       Date:  2010-10-25       Impact factor: 5.236

5.  Synthesis of 5-iodo-1,4-disubstituted-1,2,3-triazoles mediated by in situ generated copper(I) catalyst and electrophilic triiodide ion.

Authors:  Wendy S Brotherton; Ronald J Clark; Lei Zhu
Journal:  J Org Chem       Date:  2012-07-19       Impact factor: 4.354

6.  Total synthesis of sporolide B and 9-epi-sporolide B.

Authors:  K C Nicolaou; Jianhua Wang; Yefeng Tang; Lorenzo Botta
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

7.  Ruthenium(II)-catalyzed selective intramolecular [2 + 2 + 2] alkyne cyclotrimerizations.

Authors:  Yoshihiko Yamamoto; Takayasu Arakawa; Ryuji Ogawa; Kenji Itoh
Journal:  J Am Chem Soc       Date:  2003-10-08       Impact factor: 15.419

8.  Highly regioselective nitrile oxide dipolar cycloadditions with ortho-nitrophenyl alkynes.

Authors:  Melissa L McIntosh; Michael R Naffziger; Bradley O Ashburn; Lev N Zakharov; Rich G Carter
Journal:  Org Biomol Chem       Date:  2012-10-23       Impact factor: 3.876

9.  The synthesis of highly substituted isoxazoles by electrophilic cyclization: an efficient synthesis of valdecoxib.

Authors:  Jesse P Waldo; Richard C Larock
Journal:  J Org Chem       Date:  2007-11-03       Impact factor: 4.354

10.  Discovery and structure-activity relationships of sulfonamide ETA-selective antagonists.

Authors:  P D Stein; D M Floyd; S Bisaha; J Dickey; R N Girotra; J Z Gougoutas; M Kozlowski; V G Lee; E C Liu; M F Malley
Journal:  J Med Chem       Date:  1995-04-14       Impact factor: 7.446

View more
  7 in total

1.  On-Surface Azide-Alkyne Cycloaddition Reaction: Does It Click with Ruthenium Catalysts?

Authors:  Tiexin Li; Essam M Dief; Zlatica Kalužná; Melanie MacGregor; Cina Foroutan-Nejad; Nadim Darwish
Journal:  Langmuir       Date:  2022-04-26       Impact factor: 4.331

Review 2.  Ruthenium-Catalyzed Cycloadditions to Form Five-, Six-, and Seven-Membered Rings.

Authors:  Rosalie S Doerksen; Tomáš Hodík; Guanyu Hu; Nancy O Huynh; William G Shuler; Michael J Krische
Journal:  Chem Rev       Date:  2021-02-12       Impact factor: 60.622

3.  Synthesis of 3,4,5-trisubstituted isoxazoles in water via a [3 + 2]-cycloaddition of nitrile oxides and 1,3-diketones, β-ketoesters, or β-ketoamides.

Authors:  Md Imran Hossain; Md Imdadul H Khan; Seong Jong Kim; Hoang V Le
Journal:  Beilstein J Org Chem       Date:  2022-04-22       Impact factor: 2.544

4.  Facile synthesis of O-acylhydroxamates via reaction of oxime chlorides with carboxylic acids.

Authors:  Kai-Kai Wang; Yan-Li Li; Ying-Chao Zhao; Shan-Shan Zhang; Rongxiang Chen; Aili Sun
Journal:  RSC Adv       Date:  2021-12-20       Impact factor: 3.361

5.  Synthesis of C4-alkynylisoxazoles via a Pd-catalyzed Sonogashira cross-coupling reaction.

Authors:  Wen Yang; Yongqi Yao; Xin Yang; Yingying Deng; Qifu Lin; Dingqiao Yang
Journal:  RSC Adv       Date:  2019-03-18       Impact factor: 4.036

6.  Functionalized C3-Symmetric Building Blocks-The Chemistry of Triaminotrimesic Acid.

Authors:  Lisa Schmidt; Danny Wagner; Martin Nieger; Stefan Bräse
Journal:  Molecules       Date:  2022-07-07       Impact factor: 4.927

7.  Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists.

Authors:  Femke A Meijer; Richard G Doveston; Rens M J M de Vries; Gaël M Vos; Alex A A Vos; Seppe Leysen; Marcel Scheepstra; Christian Ottmann; Lech-Gustav Milroy; Luc Brunsveld
Journal:  J Med Chem       Date:  2019-12-24       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.